Micafungin
| Effect of ECMO | Moderate CS |
|---|---|
| Dose recommendation | Consider increase in dose |
| Comments, reference | Moderate CS, a case report, and favorable safety profile support dose increase, e.g., 150 mg q24h (Crit Care 2024;28:326). |
| Effect of ECMO | Moderate CS |
|---|---|
| Dose recommendation | Consider increase in dose |
| Comments, reference | Moderate CS, a case report, and favorable safety profile support dose increase, e.g., 150 mg q24h (Crit Care 2024;28:326). |